Literature DB >> 1888190

[Conversion of CPT-11 into SN-38 in human tissues].

A Kono1, Y Hara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1888190

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN： 0385-0684


× No keyword cloud information.
  4 in total

1.  Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.

Authors:  Zenichi Morise; Atsushi Sugioka; Ryoichi Kato; Junko Fujita; Sojun Hoshimoto; Takazumi Kato
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

2.  UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.

Authors:  Yoshinori Miyata; Tetsuo Touyama; Takaya Kusumi; Yoshitaka Morita; Nobuyuki Mizunuma; Fumihiro Taniguchi; Mitsuaki Manabe
Journal:  Int J Clin Oncol       Date:  2015-12-28       Impact factor: 3.402

3.  Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome.

Authors:  Hirotoshi Iihara; Hironori Fujii; Chiaki Yoshimi; Ryo Kobayashi; Nobuhisa Matsuhashi; Takao Takahashi; Kazuhiro Yoshida; Akio Suzuki
Journal:  Cancer Chemother Pharmacol       Date:  2018-12-18       Impact factor: 3.333

4.  Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer.

Authors:  Hironori Fujii; Yunami Yamada; Daichi Watanabe; Nobuhisa Matsuhashi; Takao Takahashi; Kazuhiro Yoshida; Akio Suzuki
Journal:  Cancer Chemother Pharmacol       Date:  2018-10-30       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.